Tag Archives: Scancell

June, 2016

  • 17 June

    Scancell Halts Melanoma Vaccine Trial due to Drug Problems

    Scancell Holdings Plc, (AIM:SCLP), the developer of novel Immunotherapies for the treatment of cancer, announces that it is suspending dosing with the current clinical trial supplies of SCIB1 with immediate effect. Ongoing quality control analysis has revealed that the stored drug product is no longer within the original specification. In discussion with …